Preferred Label : Hypercalcemia, infantile, 1;
Symbol : HCINF1;
CISMeF acronym : HCINF1;
Type : Phenotype, molecular basis known;
Alternative titles and symbols : Hypercalcemia, idiopathic, of infancy;
Description : Infantile hypercalcemia is characterized by severe hypercalcemia, failure to thrive,
vomiting, dehydration, and nephrocalcinosis. An epidemic of idiopathic infantile hypercalcemia
occurred in the United Kingdom in the 1950s after the implementation of an increased
prophylactic dose of vitamin D supplementation; however, the fact that most infants
receiving the prophylaxis remained unaffected suggested that an intrinsic hypersensitivity
to vitamin D might be implicated in the pathogenesis (summary by Schlingmann et al.,
2011).;
Inheritance : Autosomal recessive;
Molecular basis : Caused by mutation in cytochrome P450, family 24, subfamily A, polypeptide-1 gene
(CYP24A1, 126065.0001);
Laboratory abnormalities : Hypercalcemia; Hypercalciuria; Dehydration;
Prefixed ID : #143880;
Origin ID : 143880;
UMLS CUI : C4310232;
Automatic exact mappings (from CISMeF team)
Currated CISMeF NLP mapping
Genes related to phenotype
HPO term(s)
ORDO concept(s)
Semantic type(s)
UMLS correspondences (same concept)